public health

Federal representatives discuss CME collaboration opportunities

...

Accreditors Promote Collaboration across the Medical Education Continuum

The ACCME participated in the following events to support the ongoing ...

Brookings Institution Meeting Explores the Role of CE in REMS

Graham McMahon, MD, MMSc, President and CEO, ACCME; and Kate Regnier, MA, MBA, Executive Vice President,...

Ebola Education Materials, Posted October 22

The American Hospital Association (AHA) has provided additional educational materials for CME providers to use:

Ebola...

CME's Role in Medical Education Continuum Discussed at AIAMC Meeting

Murray Kopelow, MD, President and CEO, ACCME, gave a presentation at the 2014 ...

The ACCME submitted a comment to the Centers for Medicare & Medicaid Services (CMS) regarding the...

On July 9, the US Food and Drug Administration (FDA) released its Risk Evaluation and Mitigation Strategy or REMS for extended-release and long-acting (ER/LA) opioid analgesics.

The centerpiece of the ER/LA Opioid Analgesic...

Physician Leaders Address Role of CE in REMS

Kim Edward LeBlanc, MD, PhD, Chair, ACCME Board of Directors; Victor Reus, MD, Vice Chair, ACCME Board of Directors; and Graham McMahon,...

Video Interviews Describe Ebola CE at Rush University Medical Center

In this video interview series, leadership from Rush University Medical Center discuss...

FDA REMS Meetings, Fact Sheet for CME Providers

The ACCME has participated in two meetings with the Food and Drug Administration (FDA) about Risk Evaluation and Mitigation Strategies (REMS). We...

Last Revised:
August 27, 2012

The ACCME appreciates that the FDA recognizes the value of accredited education and chose to leverage the CE system to carry out this important public health initiative. The ACCME has a long-standing commitment to supporting the...

Pages